XOLAIR
XOLAIR
Approved
DIN Number
02260565
Drug Class
Human
Market Date
Feb 3, 2005
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02260565
AIG Number0150422001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
R03DX05 OMALIZUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification90:28.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
OMALIZUMABActive
Strength: 150 MG / VIAL
Monograph: OMALIZUMAB